Albert Osterhaus is the Chief Scientific Officer of ViroNovative, Viroscope and ViroClinics, being responsible for the scientific direction of the businesses.
He is professor of virology at the Department of Virology of EramsusMC, Rotterdam, where he leads a cross-disciplinary team of over 100 scientists, MD's, DVM's, technicians and students. He is a co-founder of ViroNovative BV and Viroscope, the other members in ViroVentures.
His interest in virology started while studying for his veterinary degree at the University of Utrecht and he went on to obtain a PhD. He worked at the National Institute of Public Health, becoming Head of Laboratory, prior to moving to Rotterdam. His research activities have grown to span many types of viruses, focussing largely in the respiratory area. He is leading contributor to our understanding of major human pathogens such as hMPV, RSV, influenza and SARS, publishing over 550 papers and an inventor of numerous patents. He has become an internationally respected scientist, serving on editorial boards of several scientific journals and on scientific advisory boards for various international and governmental health organizations, including WHO committees, the National Health Council and he is Chairman of the European Scientific Working Group on Influenza.
|
